Brief introduction on the development of Chinese Pharmacopoeia 2025 Edition
10.19778/j.chp.2025.01.001
- VernacularTitle:2025年版《中国药典》制修订情况概述
- Author:
HONG Xiaoxu
;
SONG Zonghua
;
MA Shuangcheng
;
LAN Fen
;
SHU Rong
- Publication Type:Journal Article
- Keywords:
Chinese Pharmacopoeia 2025 Edition(ChP 2025);
drug standards;
quality control
- From:
Drug Standards of China
2025;26(1):001-010
- CountryChina
- Language:Chinese
-
Abstract:
The Pharmacopoeia of the People’s Republic of China 2025 edition is to be issued in March 2025. Chinese Pharmacopoeia is the basic requirements on the drug manufacture, drug testing, drug use and drug administration. The new edition Chinese Pharmacopoeia will be dramatically improved on the pharmacopoeia monographs included, establishing the standards system, standards conversion and application of drug quality control for the new technology, new method & new tool, drug control on the safety and effectiveness as well as the drug standard international harmonization. It will take important role on improving the drug quality, ensuring the safety of drugs for public use, strengthen technical support for drug administration, promoting the high-quality development of China’s medical and pharmaceutical industry. This paper introduces the development and revision of the Chinese Pharmacopoeia 2025 Edition,aim at helping the industries well understanding and implantation the new edition Chinese Pharmacopoeia.
- Full text:202503111259543558320250201.pdf
